Pediatric Perfusion Market Report 2025

The pediatric perfusion market size has grown strongly in recent years. It will grow from $2.66 billion in 2024 to $2.85 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to early pediatric cardiac surgery milestones, pioneering perfusion techniques, the evolution of pediatric perfusion equipment, foundational research in pediatric cardiology, emergence of pediatric heart centers.

The pediatric perfusion market size is expected to see strong growth in the next few years. It will grow to $4 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to the global expansion of pediatric cardiac services, advancements in neuroprotection, investments in pediatric cardiac care, customized perfusion solutions, rise in hybrid operating room usage. Major trends in the forecast period include research in pediatric cardiac care, continuous education and training, focus on neuroprotection, pediatric-specific equipment development, and evolving cannulation techniques.

The burgeoning prevalence of cardiac congenital disorders is anticipated to propel the growth trajectory of the pediatric perfusion market in the forthcoming years. These disorders, existing at birth, significantly impact heart development and functionality, influencing blood circulation to the body's organs. Pediatric perfusion plays a pivotal role in cardiac surgeries aimed at rectifying structural heart defects, encompassing procedures such as VSD repair, ASD repair, TOF repair, coarctation of the aorta repair, among others. As of February 2023, the World Health Organization highlighted that globally, congenital diseases cause 240,000 newborn deaths within 28 days annually. Correspondingly, the CDC's January 2022 report indicated that approximately 40,000 births in the United States annually are affected by congenital cardiac abnormalities, constituting roughly 1% of the global population. This prevalence remains a driving force behind the growth of the pediatric perfusion sector.

The rise in healthcare expenditure is anticipated to drive growth in the pediatric perfusion market in the coming years. Healthcare expenditure encompasses the total resources, typically measured in monetary terms, that a country, government, organization, or individual allocates to healthcare-related goods and services. An increase in healthcare expenditure enables the acquisition and maintenance of advanced medical technologies, including perfusion systems specifically designed for pediatric patients. Healthcare facilities with sufficient funding can implement cutting-edge perfusion technologies to improve the quality of pediatric cardiac surgeries. For instance, the economic forecast from the Office for Budget Responsibility (OBR) and Treasury indicates that planned health spending in the UK is projected to increase from £182 billion ($231.7 billion) in 2022/23 to £192 billion ($244.43 billion) in 2024/25. Furthermore, the National Health Expenditures Accounts (NHEA) by KFF, a U.S.-based independent source for health policy research, forecasting, and journalism, predicts that health spending in the USA will grow by 5% from 2023 to 2024, reaching $4.9 trillion. Consequently, the increase in healthcare expenditure is propelling the growth of the pediatric perfusion market.

Product innovations stand as a prominent trend gaining momentum within the pediatric perfusion market. Leading market players are intensely focused on pioneering newer technologies, encompassing advancements in cardiopulmonary bypass (CPB), cardiovascular perfusion, and extracorporeal systems such as miniaturized extracorporeal circulation (MECC). Notably, in March 2023, LivaNova, a UK-based medical devices manufacturer, introduced the Essenz Heart-Lung Machine in the US region, securing a 510(k) clearance from the U.S. Food and Drug Administration. This sophisticated perfusion system, utilized during cardiopulmonary bypass surgeries, emulates the functions of a patient's heart and lungs during open-heart procedures. Its adaptability for both adult and pediatric patients, along with its mast-mounted design ensuring minimal interference and cleanliness, showcases its effectiveness. The centralized cockpit offers a comprehensive vantage point to manage the device, monitor perfusion and patient data, and seamlessly integrate with external operating room devices and hospital information systems.

Key companies operating within the pediatric perfusion market are driving profitability through innovative products such as Perfusion Circuits. These specialized tubing kits cater to the unique blood and oxygen management requirements during cardiovascular procedures. A case in point is Terumo Cardiovascular Systems Corporation, which, in September 2022, unveiled Perfusion Circuits to fortify its global leadership in perfusion products. These circuits facilitate oxygen-carbon dioxide exchange during cardiac surgeries and are customized for cardiovascular procedures. Additionally, they bolster local manufacturing capabilities in Costa Rica, further supporting the company's market expansion endeavors.

In March 2022, Medtronic plc, a US-based company operating in healthcare technology acquired Affera, Inc. for an undisclosed amount. Through this acquisition, Medtronic plc aims to broaden its cardiac ablation portfolio by adding its first-ever cardiac mapping and navigation platform including distinct, fully integrated diagnostic, focal pulsed field, and radiofrequency ablation solution. Affera Inc is a US-based medical technology company for cardiac disorders.

Major companies operating in the pediatric perfusion market include Medtronic plc, Terumo Cardiovascular Systems Corporation, LivaNova PLC, B. L. Lifesciences Pvt. Ltd., Eurosets, GE HealthCare Technologies Inc., Nonin Medical Inc., Koninklijke Philips N.V., Sorin Group, Cardinal Health Inc, Fluigent, Getinge AB, Xvivo Perfusion AB, Masimo Corporation, Philips Healthcare, Edwards Lifesciences Corporation, Maquet Holding B.V. & Co. KG, Smiths Medical Inc., Fresenius Kabi AG, Nipro Medical Corporation, Hemovent GmbH, Spectrum Medical Ltd., Braile Biomédica, Leviticus Cardio Ltd., Medos Medizintechnik AG, Beijing Medos Electronic Medical Equipment Co. Ltd., Medline Industries Inc., B. Braun Melsungen AG, Baxter International Inc., ALung Technologies Inc., Novalung GmbH, SynCardia Systems LLC, Xenios AG.

North America was the largest region in the pediatric perfusion market in 2024. The regions covered in the pediatric perfusion market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pediatric perfusion market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Pediatric perfusion serves as a critical medical mechanism responsible for circulating blood throughout a pediatric patient's body, ensuring stable blood pressure, adequate oxygen levels, and uniform distribution of blood to all bodily components.

Key pediatric perfusion products encompass pediatric cannulae, pediatric centrifugal blood pumps, pediatric arterial filters, hem concentrators, HMS plus hemostasis management systems, and pediatric oxygenators. Pediatric cannulae, small tubes inserted into a pediatric patient's vein or bodily cavities such as the nose, play a pivotal role in delivering intravenous (IV) therapy. These tools find application in various medical procedures including pediatric cardiac surgeries, organ transplantation in pediatric patients, and pediatric extracorporeal life support (ECLS). End-users such as hospitals, clinics, ambulatory surgical centers, among others, rely on these products for pediatric care.

The pediatric perfusion market research report is one of a series of new reports that provides pediatric perfusion market statistics, including pediatric perfusion industry global market size, regional shares, competitors with a pediatric perfusion market share, detailed pediatric perfusion market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric perfusion industry. This pediatric perfusion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pediatric perfusion market consists of sales of heart-lung machines, oxygenators, blood pumps, cannulas, temperature management systems, and monitoring devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.